Antibiotic use in Crohn's disease: why and how?
C Prantera1, M L Scribano, E Berto
1Gastroenterology Division, Ospedale Nuovo Regina Margherita, Rome, Italy.
Summary
Antibiotics may help manage Crohn's disease by targeting gut bacteria that amplify inflammation. Combination therapy with metronidazole and ciprofloxacin shows promise for complications and flares.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Gut bacteria are implicated in Crohn's disease (CD) symptoms and complications.
- The exact mechanisms by which antibiotics benefit CD patients remain unclear.
- While specific pathogens causing flares are rare, the gut microflora amplifies CD inflammation.
Purpose of the Study:
- To explore the role of gut bacteria in Crohn's disease.
- To review the efficacy of antibiotics in managing CD.
- To understand how antibiotics might alleviate CD symptoms and complications.
Main Methods:
- Review of existing data and hypotheses regarding gut microbiota in CD.
- Analysis of antibiotic use in Crohn's disease treatment.
- Examination of evidence for specific antibiotic combinations.
Main Results:
- Antibiotics are widely used for CD symptom improvement and remission induction, despite inconclusive trial data.
- A combination of metronidazole and ciprofloxacin is effective for CD complications.
- This antibiotic combination appears beneficial for acute flares, as an alternative or adjunct to corticosteroids.
Conclusions:
- Gut microflora significantly contributes to perpetuating inflammation in Crohn's disease.
- Antibiotic therapy, particularly metronidazole and ciprofloxacin, offers a viable treatment option for CD complications and flares.
- Further controlled trials are needed to fully elucidate the role and efficacy of antibiotics in CD management.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.